Laure Farnault Selected Research

Sepsis (Septicemia)

1/2018

A transcriptomic signature predicting septic outcome in patients undergoing autologous stem cell transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laure Farnault Research Topics

Disease

9	Neoplasms (Cancer) 07/2023 - 01/2012
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 01/2018
5	Lymphoma (Lymphomas) 03/2022 - 01/2016
3	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 12/2010
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2023 - 01/2023
2	Leukemia 06/2023 - 06/2021
2	Multiple Myeloma 10/2019 - 01/2018
1	Exanthema (Rash) 11/2023
1	Monoclonal Gammopathy of Undetermined Significance 11/2023
1	Ataxia (Dyssynergia) 11/2023
1	COVID-19 01/2022
1	Plasmablastic Lymphoma 04/2021
1	Frailty 12/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020
1	Histiocytosis 01/2020
1	Hemorrhage 01/2019
1	Atrial Fibrillation 01/2019
1	Sepsis (Septicemia) 01/2018
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2018
1	Lymphocytosis 01/2016
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 04/2013
1	Infections 01/2012
1	Cytomegalovirus Infections (Inclusion Disease) 01/2012

Drug/Important Bio-Agent (IBA)

4	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2021 - 01/2018
2	Azacitidine (5 Azacytidine)FDA Link 11/2023 - 01/2023
2	CPX-351IBA 07/2023 - 10/2021
2	Methotrexate (Mexate)FDA LinkGeneric 03/2022 - 08/2021
1	Immunoglobulin M (IgM)IBA 11/2023
1	lutetium Lu 177 dotatateIBA 07/2023
1	AcidsIBA 06/2023
1	VaccinesIBA 01/2022
1	Oxygen (Dioxygen)IBA 11/2021
1	Daunorubicin (Cerubidine)FDA LinkGeneric 10/2021
1	Liposomes (Liposome)IBA 10/2021
1	AnthracyclinesIBA 06/2021
1	daratumumabIBA 04/2021
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 12/2020
1	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 12/2020
1	C-Reactive ProteinIBA 12/2020
1	Biomarkers (Surrogate Marker)IBA 12/2020
1	trametinibIBA 01/2020
1	blinatumomabIBA 01/2020
1	Lenalidomide (CC 5013)FDA Link 10/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2019
1	Bortezomib (Velcade)FDA Link 10/2019
1	purineIBA 09/2019
1	AnticoagulantsIBA 01/2019
1	ibrutinibIBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016
1	Prednisone (Sone)FDA LinkGeneric 01/2016
1	Vincristine (Oncovin)FDA LinkGeneric 01/2016
1	Rituximab (Mabthera)FDA Link 01/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016
1	Histocompatibility Antigens Class IIBA 12/2013
1	Janus KinasesIBA 04/2013
1	PerforinIBA 01/2012
1	Busulfan (Busulfex)FDA Link 12/2010
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2010
1	thymoglobulin FDA Link 12/2010

Therapy/Procedure

6	Therapeutics 07/2023 - 01/2012
3	Transplantation 07/2023 - 01/2012
3	Stem Cell Transplantation 12/2013 - 12/2010
2	Renal Dialysis (Hemodialysis) 03/2022 - 08/2021
1	Induction Chemotherapy 11/2023
1	Activities of Daily Living (ADL) 01/2022
1	Immunotherapy 06/2021
1	Ambulatory Care (Outpatient Care) 12/2020
1	Drug Therapy (Chemotherapy) 01/2018
1	Hematopoietic Stem Cell Transplantation 01/2018